Probi AB - Strategic SWOT Analysis Review
Description
Probi AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
Probi AB (Probi), a subsidiary of Symrise AG, is a biotechnology company that develops, produces and markets probiotics. The company offers licenses for its technology and sells finished products in bulk. It focuses on products for the improvement of gastrointestinal health and the immune system. Probi offers an array of probiotic products in various forms, such as powders, capsules, tablets, and foods. The company sells its products under the brand name Probi. Its customers primarily consist of health, pharmaceutical, and food companies. The company’s products are used in various applications, including dietary supplements, food and beverages. The company has an operational presence in Sweden, Europe, North America, and the Asia Pacific. Probi is headquartered in Lund, Sweden.
Probi AB Key Recent Developments
Oct 29,2025: Probi Achieves 44% Reduction in Carbon Emissions Since 2019
Sep 22,2025: Probi Wins Third NutraIngredients Award for Women’s Health with Recognition Extending to Asia
Reasons to Buy
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Probi AB (Probi), a subsidiary of Symrise AG, is a biotechnology company that develops, produces and markets probiotics. The company offers licenses for its technology and sells finished products in bulk. It focuses on products for the improvement of gastrointestinal health and the immune system. Probi offers an array of probiotic products in various forms, such as powders, capsules, tablets, and foods. The company sells its products under the brand name Probi. Its customers primarily consist of health, pharmaceutical, and food companies. The company’s products are used in various applications, including dietary supplements, food and beverages. The company has an operational presence in Sweden, Europe, North America, and the Asia Pacific. Probi is headquartered in Lund, Sweden.
Probi AB Key Recent Developments
Oct 29,2025: Probi Achieves 44% Reduction in Carbon Emissions Since 2019
Sep 22,2025: Probi Wins Third NutraIngredients Award for Women’s Health with Recognition Extending to Asia
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Table of Contents
31 Pages
- Section 1 - About the Company
- Probi AB - Key Facts
- Probi AB - Key Employees
- Probi AB - Key Employee Biographies
- Probi AB - Major Products and Services
- Probi AB - History
- Probi AB - Company Statement
- Probi AB - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Section 2 – Company Analysis
- Company Overview
- Probi AB - Business Description
- Geographical Segment: APAC
- Performance
- Geographical Segment: EMEA
- Performance
- Geographical Segment: The Americas
- Performance
- R&D Overview
- Probi AB - Corporate Strategy
- Probi AB - SWOT Analysis
- SWOT Analysis - Overview
- Probi AB - Strengths
- Probi AB - Weaknesses
- Probi AB - Opportunities
- Probi AB - Threats
- Probi AB - Key Competitors
- Section 3 – Company’s Lifesciences Financial Deals and Alliances
- Probi AB, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
- Probi AB, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
- Probi AB, Recent Deals Summary
- Section 4 – Company’s Recent Developments
- Oct 29, 2025: Probi Achieves 44% Reduction in Carbon Emissions Since 2019
- Sep 22, 2025: Probi Wins Third NutraIngredients Award for Women’s Health with Recognition Extending to Asia
- Section 5 – Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Probi AB, Key Facts
- Probi AB, Key Employees
- Probi AB, Key Employee Biographies
- Probi AB, Major Products and Services
- Probi AB, History
- Probi AB, Subsidiaries
- Probi AB, Key Competitors
- Probi AB, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
- Probi AB, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
- Probi AB, Recent Deals Summary
- List of Figures
- Probi AB, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
- Probi AB, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
